Levamisole in steroid-sensitive nephrotic syndrome of childhood: The lost paradise?

Pediatric Nephrology

Volumn 20, Issue 1, 2005, Pages 10-14

  Davin, J C ^a   Merkus, M P ^a  

^a EMMA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

Frequent relapsers; Idiopathic nephrotic syndrome; Levamisole; Steroid dependent nephrotic syndrome

Indexed keywords

ALKYLATING AGENT; CYCLOPHOSPHAMIDE; CYCLOSPORIN; LEVAMISOLE; PREDNISONE; STEROID;

ARTICLE; AZOOSPERMIA; CANCER; CANCER RISK; CHILD; CHILDHOOD DISEASE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONSENSUS DEVELOPMENT; CONVULSION; DRUG APPROVAL; DRUG CARCINOGENICITY; DRUG COST; DRUG DEPENDENCE; DRUG EFFICACY; DRUG INDICATION; DRUG INDUSTRY; DRUG MANUFACTURE; DRUG SAFETY; DRUG SENSITIVITY; DRUG TOLERABILITY; EUROPE; EVIDENCE BASED MEDICINE; EXPERIMENTAL DESIGN; FOLLOW UP; GINGIVA HYPERTROPHY; GROWTH DISORDER; HAIR LOSS; HIRSUTISM; HUMAN; HYPERTENSION; INFECTION; INFERTILITY; LIVER TOXICITY; NEPHROTIC SYNDROME; NEPHROTOXICITY; NEUTROPENIA; OLIGOSPERMIA; OSTEOPOROSIS; PRIORITY JOURNAL; RECURRENCE RISK; RELAPSE; RISK BENEFIT ANALYSIS; RISK REDUCTION; STATISTICAL ANALYSIS; VASCULITIS;

ADJUVANTS, IMMUNOLOGIC; CHILD; HUMANS; LEVAMISOLE; NEPHROTIC SYNDROME; RANDOMIZED CONTROLLED TRIALS;

EID: 11244283709     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-004-1615-9     Document Type: Article

References (34)

1. ISKDC (1978) The primary nephrotic syndrome in children: Prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. A report of the International Study of Kidney Disease in Children. Kidney Int 13:159-165
2. Mathieson PW (2003) Immune dysregulation in minimal change nephropathy. Nephrol Dial Transplant 18 [Suppl 6]:26-29
3. Niaudet P (2004) Steroid-sensitive nephrotic syndrome in children. In: Avner ED, Harmon WE, Niaudet P (eds) Pediatric nephrology. Lippincott Williams and Wilkins, Philadelphia, pp 543-556
4. Chiu J, McLaine PN, Drummond KN (1973) A controlled prospective study of cyclophosphamide in relapsing, corticosteroid-responsive, minimal-lesion nephrotic syndrome in childhood. J Pediatr 82:607-613
5. Barratt TM, Soothill JF (1970) Controlled trial of cyclophosphamide in steroid-sensitive relapsing nephrotic syndrome of childhood. Lancet II:479-482
6. Durkan A, Hodson E, Willis N, Craig J (2001) Non-corticosteroid treatment for nephrotic syndrome in children. Kidney Int 59:1919-1926
7. Latta K, Schnakenburg C von, Ehrich J (2001) A meta-analysis of cytotoxic treatment for frequently relapsing nephrotic syndrome in children. Pediatr Nephrol 16:271-282
8. Szeto CC, Gillespie KM, Mathieson PW (2000) Levamisole induces interleukin 18 and shifts TH1/TH2 balance. Immunology 100:217-224
9. Tanphaichitr P, Tanphaichitr D, Sureeratanan J, Chatasingh S (1980) Treatment of nephrotic syndrome with levamisole. J Pediatr 96:490-493
10. Rashid HU, Ahmed S, Fatima N, Khanam A (1996) Levamisole in the treatment of steroid dependent or frequent relapsing nephritic syndrome in children. Bangladesh Ren J 15:6-8
11. Niaudet P, Drachman R, Gagnadoux MF, Broyer M (1984) Treatment of idiopathic nephrotic syndrome with levamisole. Acta Paediatr Scand 73:637-641
12. La Manna A, Polito C, Del Gado R, Foglia AC (1988) Levamisole in children's idiopathic nephrotic syndrome. Child Nephrol Urol 9:200-202
13. Drachman R, Schlesinger M, Alon U, Mor J, Etzioni A, Shapira H, Ohali M, Drukker A (1988) Immunoregulation with levamisole in children with frequently relapsing steroid responsive nephrotic syndrome. Acta Paediatr Scand 77:721-726
14. BAPN (British Association for Paediatric Nephrology) (1991) Levamisole for corticosteroid-dependent nephrotic syndrome in childhood. Lancet 337:1555-1557
15. Dayal U, Dayal AK, Shastry JC, Raghupathy P (1994) Use of levamisole in maintaining remission in steroid-sensitive nephrotic syndrome in children. Nephron 66:408-412
16. Meregalli P, Bianchetti MG, Imoberdorf G, Lutschg J, Reymond D, Oetliker OH (1994) Levamisole in children with frequently recurring idiopathic nephrotic syndrome. Schweiz Med Wochenschr 124:801-805
17. Mongeau JG, Robitaille PO, Roy F (1988) Clinical efficacy of levamisole in the treatment of primary nephrosis in children. Pediatr Nephrol 2:398-401
18. Mancini ML, Rinaldi S, Rizzoni G (1974) Treatment of partially corticosteroid-sensitive nephrotic syndrome with levamisole. Pediatr Nephrol 8:788
19. Bagga A, Sharma A, Srivasta RN (1997) Levamisole therapy in corticosteroid-dependent nephrotic syndrome. Pediatr Nephrol 11:415-417
20. Kemper MJ, Amon O, Timmermann K, Altrogge H, Muller-Wiefel DE (1998) The treatment with levamisole of frequently recurring steroid-sensitive idiopathic nephrotic syndrome in children. Deutsch Med Wochenschr 123:239-243
21. Tenbrock K, Müler-Berghaus J, Fuchshuber A, Michalk D, Querfeld U (1998) Levamisole treatment in steroid-sensitive and steroid-resistant nephrotic syndrome. Pediatr Nephrol 12:459-462
22. Ginevri F, Trivelli A, Ciardi MR, Ghiggeri GM, Parfumo F, Gusmano R (1996) Protracted levamisole in children with frequent-relapse nephrotic syndrome. Pediatr Nephrol 10:550
23. Fu LS, Chi CS (2000) Levamisole in steroid-sensitive nephrotic syndrome children with steroid-dependency and/or frequent relapses. Acta Paediatr Taiwan 41:80-84
24. Alsaran K, Grisaru S, Stephens D, Arbus G (2001). Levamisole vs. cyclophosphamide for frequently-relapsing steroid-dependent nephrotic syndrome. Clin Nephrol 56:289-294
25. Donia AF, Amer GM, Ahmed HA, Gazareen SH, Moustafa FE, Shoeib AA, Ismail AM, Khamis S, Sobh MA (2002) Levamisole: Adjunctive therapy in steroid-dependent minimal change nephrotic children. Pediatr Nephrol 17:355-358
26. Alshaya HO, Kari JA (2002) Levamisole treatment in steroid sensitive nephrotic syndrome. Saudi Med J 23:1101-1104
27. Abeyagunawardena AS, Dillon MJ, Rees L, Hoff W van't, Trompeter RS (2003) The use of steroid-sparing agents in steroid-sensitive nephrotic syndrome. Pediatr Nephrol 18:919-924
28. Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, Tugwell P, Klassen TP (1998) Does quality of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 352:609-613
29. Schulz KF, Chalmers I, Hayes RJ, Altman DG (1995) Empirical evidence of bias: Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 273:408-412
30. Barbano G, Ginevri F, Ghiggeri GM, Gusmano R (1999) Disseminated autoimmune disease during levamisole treatment of nephrotic syndrome. Pediatr Nephrol 13:602-603
31. Bulugahapitiya DT (1997) Liver toxicity in a nephrotic patient treated with levamisole. Arch Dis Child 76:289
32. Palcoux JB, Niaudet P, Goumy P (1994) Side effects of levamisole in children with nephrosis. Pediatr Nephrol 8:263-264
33. Coutinho HM, Groothoff JW, Offringa MO, Gruppen MP, Heymans HSA (2001) De novo malignancy after paediatric renal replacement therapy. Arch Dis Child 85:478-483
34. Knudson AG (1996) Hereditary cancer: Two hits revisited. J Cancer Res Clin Oncol 122:135-140